Status:
RECRUITING
Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
Lead Sponsor:
University of Rochester
Collaborating Sponsors:
National Institute of Neurological Disorders and Stroke (NINDS)
Conditions:
Myotonic Dystrophy
Facioscapulohumeral Muscular Dystrophy
Eligibility:
All Genders
Brief Summary
Myotonic dystrophy (DM) and facioscapulohumeral muscular dystrophy (FSHD) are inherited disorders characterized by progressive muscle weakness and loss of muscle tissue. The purpose of this registry i...
Detailed Description
The National Registry of DM and FSHD Patients and Family Members was developed to create a link between patients and scientists in order to promote research on these rare illnesses. The Registry is sp...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Diagnosed with DM, FSHD, or related diseases or are an unaffected family member of someone diagnosed with one of these diseases
Exclusion
Key Trial Info
Start Date :
September 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2028
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT00082108
Start Date
September 1 2000
End Date
June 1 2028
Last Update
October 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rochester Medical Center, Department of Neurology
Rochester, New York, United States, 14642